MyFinsight
Home
Blog
About
Back
Income Statement
Candel Therapeutics, Inc. (CADL)
Candel Therapeutics, Inc. (CADL)
source: myfinsight.com
Net income (loss)
and comprehensive...
-$38,905K
(-711.20%↓ Y/Y)
Loss from operations
-$26,746K
(-139.29%↓ Y/Y)
Total other income
(expense), net
-$12,159K
(-290.55%↓ Y/Y)
Interest income
$1,672K
(80.56%↑ Y/Y)
Grant income
$22K
Total operating
expenses
$26,746K
(139.29%↑ Y/Y)
Change in fair value of
warrant liabilities
$12,278K
(315.74%↑ Y/Y)
Interest expense
$1,575K
(567.37%↑ Y/Y)
Research and development
$19,801K
(183.24%↑ Y/Y)
General and
administrative
$6,945K
(65.91%↑ Y/Y)
Back